Bioengineering news +
Biosimilar cancer treatment for Indonesia
02 November 2015 | Jakarta
Complex therapy developer ProBioGen has signed an agreement to develop biosimilar Trastuzumab for cancer with Indonesia-based vaccine manufacturer Bio Farma... readmore

FTC asks FDA to reconsider naming proposal
29 October 2015 | Washington DC
The US Food and Drug Administration’s (FDA) naming guidance on biosimilars may hinder competition, according to the Federal Trade Commission (FTC)... readmore

Kite Pharma to collaborate with AIS on cancer research
29 October 2015 | Santa Monica
Kite Pharma has entered an agreement with biotechnology firm Alpine Immune Systems (AIS) to discover and develop protein-based immotherapies to treat cancer... readmore

Vertex and CRISPR strike gene editing deal
27 October 2015 | Massachusetts
Vertex Pharmaceuticals and CRISPR Therapeutics have entered into a research collaboration to develop new treatments aimed at the underlying genetic causes of human diseases... readmore

Don't rewrite the test at Sequenom’s behest, says Ariosa
23 October 2015 | Washington DC
Ariosa Diagnostics has demanded the US Court of Appeals for the Federal Circuit deny Sequenom’s petition for an en banc rehearing... readmore

Luc Therapeutics does depression treatment deal with Novartis
22 October 2015 | Massachusetts
Biotechnology firm Luc Therapeutics was entered a licensing deal with Novartis to develop its depression treatment, N2RB NAM... readmore

Amgen tries to stop biosimilar launch
20 October 2015 | Florida
Amgen has asked a Florida federal court to stop Apotex from marketing its biosimilar of white blood cell treatment Neulasta... readmore

FIRST << 1 2 3 4 5 6 7 >> LAST

FaceBook LinkedIn RSS feed Blog Instagram Twitter
Specialist features +
Country profiles ++
Interviews +++
Matters of import
20 January 2016
Alireza Behrooz of Merchant & Gould and Nick Phillips of Edwin Coe discuss parallel importation of pharmaceuticals in the US and Europe readmore

Raising the bar
16 December 2015
Amendments to the US Civil Rules of Procedure could dissuade some non-practicing entities from targeting technology-rich sectors readmore

Making connections
02 December 2015
Changes are coming to the UK Patent Box to meet new international standards readmore

More features
06 January 2016
Australia’s IP system has come under the spotlight as the government considers possible reforms. Naomi Pearce and Nigel Lokan of K&L Gates speak to Tammy Facey readmore

11 September 2015
Mohan Dewan and Disha Dewan of R K Dewan & Co report on the ban on any changes to patent specifications or claims at the time of national phase entry via the Patent Cooperation Treaty in India readmore

11 September 2015
The fear that natural products would be privatised soon, or one cannot study a product of nature and benefit from it if another legally possesses it, is always in the minds of all stakeholders. D. Calab Gabriel and Maria Gabriel of Lex IP Care discuss the patenting of natural bio-materials in India readmore

More country profiles
Terry Mahn
Fish & Richardson
03 February 2016
Terry Mahn of Fish & Richardson discusses the issues still to be resolved in the Food and Drug Administration’s proposed naming system for biosimilars readmore

Rogelio Nicandro
Romulo LLP
04 November 2015
Rogelio Nicandro of Romulo LLP offers some handy tips for stopping trademark infringement in the Philippines readmore

Grant Shoebridge
Shelston IP
04 November 2015
Grant Shoebridge of Shelston IP unpacks the Australian High Court’s Myriad decision readmore

More interviews
IPPro Life Sciences


Copyright (C) 2013 Black Knight Media Ltd. All rights reserved. No reproduction without prior authorization